Tenet Healthcare Co. (NYSE:THC) Shares Purchased by Vista Investment Partners LLC

Vista Investment Partners LLC grew its stake in shares of Tenet Healthcare Co. (NYSE:THC) by 1.7% during the 4th quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 24,843 shares of the company’s stock after purchasing an additional 413 shares during the period. Vista Investment Partners LLC’s holdings in Tenet Healthcare were worth $3,136,000 at the end of the most recent reporting period.

Other large investors have also made changes to their positions in the company. FMR LLC increased its holdings in Tenet Healthcare by 88.0% in the third quarter. FMR LLC now owns 7,700,693 shares of the company’s stock valued at $1,279,855,000 after buying an additional 3,604,161 shares in the last quarter. Geode Capital Management LLC increased its position in shares of Tenet Healthcare by 23.6% in the third quarter. Geode Capital Management LLC now owns 2,044,667 shares of the company’s stock valued at $339,893,000 after buying an additional 390,316 shares in the last quarter. Iron Triangle Partners LP acquired a new position in shares of Tenet Healthcare during the 3rd quarter worth $51,346,000. Allspring Global Investments Holdings LLC grew its stake in Tenet Healthcare by 344.7% in the 3rd quarter. Allspring Global Investments Holdings LLC now owns 317,198 shares of the company’s stock valued at $52,718,000 after acquiring an additional 245,875 shares during the last quarter. Finally, Point72 Asset Management L.P. raised its position in Tenet Healthcare by 32.0% during the third quarter. Point72 Asset Management L.P. now owns 442,949 shares of the company’s stock worth $73,618,000 after acquiring an additional 107,290 shares during the last quarter. Hedge funds and other institutional investors own 95.44% of the company’s stock.

Insiders Place Their Bets

In other news, EVP Lisa Y. Foo sold 4,000 shares of Tenet Healthcare stock in a transaction dated Thursday, October 31st. The stock was sold at an average price of $155.94, for a total transaction of $623,760.00. Following the sale, the executive vice president now directly owns 15,566 shares of the company’s stock, valued at approximately $2,427,362.04. The trade was a 20.44 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. 0.93% of the stock is owned by company insiders.

Analyst Upgrades and Downgrades

Several analysts have recently commented on THC shares. Wells Fargo & Company lowered shares of Tenet Healthcare from an “overweight” rating to an “equal weight” rating and lowered their price target for the company from $205.00 to $150.00 in a research report on Monday, November 25th. StockNews.com downgraded Tenet Healthcare from a “strong-buy” rating to a “buy” rating in a research report on Tuesday, December 17th. Cantor Fitzgerald upped their price objective on Tenet Healthcare from $168.00 to $177.00 and gave the company an “overweight” rating in a research report on Wednesday, October 30th. Raymond James downgraded shares of Tenet Healthcare from a “strong-buy” rating to an “outperform” rating and set a $195.00 target price for the company. in a research note on Friday, November 22nd. Finally, KeyCorp lowered their price target on shares of Tenet Healthcare from $200.00 to $185.00 and set an “overweight” rating for the company in a report on Tuesday, January 7th. Three equities research analysts have rated the stock with a hold rating, fourteen have issued a buy rating and one has assigned a strong buy rating to the company. According to data from MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and an average price target of $165.00.

Tenet Healthcare Price Performance

Shares of Tenet Healthcare stock opened at $135.50 on Friday. The stock has a market capitalization of $12.89 billion, a P/E ratio of 4.34, a PEG ratio of 0.60 and a beta of 2.06. Tenet Healthcare Co. has a twelve month low of $80.53 and a twelve month high of $171.20. The company has a current ratio of 1.58, a quick ratio of 1.52 and a debt-to-equity ratio of 2.35. The business’s fifty day moving average price is $134.94 and its 200 day moving average price is $148.10.

Tenet Healthcare (NYSE:THC) last posted its earnings results on Tuesday, October 29th. The company reported $2.93 earnings per share for the quarter, beating the consensus estimate of $2.33 by $0.60. Tenet Healthcare had a net margin of 14.91% and a return on equity of 24.05%. The business had revenue of $5.12 billion for the quarter, compared to analyst estimates of $5.05 billion. During the same quarter in the previous year, the business posted $1.44 EPS. The business’s quarterly revenue was up 1.1% on a year-over-year basis. As a group, research analysts anticipate that Tenet Healthcare Co. will post 11.37 earnings per share for the current year.

Tenet Healthcare Profile

Tenet Healthcare Corporation operates as a diversified healthcare services company in the United States. The company operates through two segments: Hospital Operations and Services, and Ambulatory Care. Its general hospitals offer acute care services, operating and recovery rooms, radiology and respiratory therapy services, clinical laboratories, and pharmacies.